Pirozzi, Christopher J.
Yan, Hai http://orcid.org/0000-0001-9509-8431
Article History
Accepted: 4 May 2021
First Online: 15 June 2021
Competing interests
: H.Y. is the chief scientific officer and has ownership interest in Genetron Holdings and receives royalties from Agios, Genetron and Personal Genome Diagnostics (PGDX). H.Y. holds a patent related to genetic alterations in <i>IDH</i> and other genes in malignant glioma (US Patent 8,685,660B2) issued, licensed and with royalties paid by Agios; a patent for genetic alterations in <i>IDH</i> and other genes in malignant glioma issued, licensed and with royalties paid by PGDX; a patent on methods for the rapid and sensitive detection of hotspot mutations (US 10,633,711B2) issued, licensed and with royalties paid by Genetron Holdings; a patent on homozygous and heterozygous <i>IDH1</i> gene-defective human astrocytoma cell lines (US 9,695,400B2); and a patent on homozygous and heterozygous <i>IDH1</i> gene-defective cell lines derived from human colorectal cells (US 9,074,221B2). C.J.P. declares no competing interests.